Small antibodies called nanobodies produced in camels, llamas, and alpacas might help stop the spread of COVID-19, but can they stand up against the competition?
Bats, pigs, and pangolins – oh my! The COVID-19 pandemic highlighted the consequences of viral spillover from animals, but it is not the first time in history that an animal virus has spurred disease in humans.
Scientists engineer the photosynthetic bacteria spirulina to produce biologics at a large enough scale to treat some of the world’s deadliest and most prevalent diseases.
Researchers pioneered a new strategy for diagnosing puzzling genetic diseases, expanding scientists’ capability to study their causes and pathophysiology.
Researchers identified common, dysregulated pathways among different cancers using a newly developed protein-protein interaction mapping technique. The results may inform treatment and lead to the development of more effective drugs for cancer.
Recent advancements in mitochondrial genome editing technologies take scientists one step closer to developing viable treatments for mitochondrial diseases, which affect 1 in 4300 adults.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.